Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Auto-Injectors Market – Insights

Auto-injectors are used to deliver a dose of a particular drug. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.

The global auto-injectors market is estimated to account for US$ 2,338.2 Mn in 2018 in terms of value and is expected to reach US$ 7,894.6 Mn by the end of 2027.

Global Auto-Injectors Market: Drivers

Increasing prevalence of multiple sclerosis (MS) is expected to boost growth of the global auto-injectors market over the forecast period. For instance, according to a study by National MS Society, published in February 2019, in the journal Neurology, in 2017, nearly 1 million adults were living with MS in the U.S.

 Moreover, increasing number of people suffering from anaphylaxis is also expected to aid in growth of the market. For instance, according to the study, ‘The Global Incidence and Prevalence of Anaphylaxis in Children in The General Population: A Systematic Review, published in January 2019, in the European Journal of Allergy and Clinical Immunology, the incidence of anaphylaxis in children worldwide ranged from 1 to 761 per 100 000 person?years for total anaphylaxis and 1 to 77 per 100 000 person?years for food?induced anaphylaxis.

North America region held dominant position in the global auto-injectors market in 2018, accounting for 75.9% share in terms of value, followed by Europe.

Auto-Injectors  | Coherent Market Insights

Global Auto-Injectors Market: Restraints

High cost of auto-injectors is a major factor hindering growth of the global auto-injectors market. For instance, the cost of EpiPen (2-pack) increased from US$ 100 in 2007 to US$ 608. Moreover, the cost of a generic EpiPen launched in December 2016 was 300% more than that in 2007.

Moreover, stringent regulatory scenario for approval of auto-injectors is also expected to hinder growth of the market. The U.S. FDA classifies auto-injectors as class II high-risk medical devices and are subject to additional control prior to receiving approval.

Global Auto-Injectors Market: Opportunities

The market in Europe is witnessing increasing shortages of epinephrine auto-injectors following manufacturing issues with the Emerade brand auto-injector. Therefore, key players in the market can focus on expanding their presence in the region.

Blockage in the needle in adrenaline auto-injectors is a common issue and may lead to failure in delivery of a dose. This increases the need for proper training and advice for patients and caregivers before using the devices. Key players can encourage end users to sign up for the Expiry Alert Service of their auto-injectors.

Auto-Injectors  | Coherent Market Insights

Prefilled Auto-Injectors sub segment in the product type segment in global auto-injectors market was valued at US$ 1,904.1 Mn in 2018 and is expected to reach US$ 7,266.6 Mn by 2027 at a CAGR of 15.1% during the forecast period.

Market Trends/Key Takeaways

The market is witnessing increasing launch of auto-injectors for infants and toddlers. For instance, in July 2019, Walgreens, a pharmacy store chain, and Kaléo, a privately-held pharmaceutical company, announced AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector – the first and only epinephrine auto-injector approved by the U.S. FDA for infants and toddlers is available at Walgreens locations.

Key players in the market are also focused on launching disposable auto-injectors. For instance,  in October 2019, Becton, Dickinson and Company launched the BD Intevia 1mL two-step disposable auto-injector.

Regulations:

U.S.

  • Pen injectors for general use are regulated as class II devices under 21 CFR 880.5860 (product code NSC) or 21 CFR 880.6920
  • Jet injectors for general use, including needle or needle-free injectors, are regulated as class II devices under 21 CFR 880.5430
  • 999 Epinephrine Auto-Injector Minnesota allows authorized entities including recreation camps, colleges, universities, preschools and day-care facilities to obtain, store, and use epinephrine auto-injectors without a prescription

Auto-Injectors  | Coherent Market Insights

Global Auto-Injectors Market: Competitive Landscape

Major players operating in the global auto-injectors market include, Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Novartis International AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.

Global Auto-Injectors Market: Key Development 

Major players in the market are focused approval and launch of generic products to enhance their market share. For instance, in August 2019, Teva Pharmaceutical Industries Ltd. launched generic version of Mylan’s EpiPen for young children.

Key players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in October 2019, Haselmeier, a manufacturer of self-injection devices, partnered with Stevanato Group, a producer of glass primary packaging based in Italy, for development, manufacturing, and supply of the axis-D pen-injector in the therapeutic area of diabetes care.

Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to use and self-administration by patients is possible. Auto-injectors come under injectable drug delivery which is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.

Restraints of the Global Auto-Injectors Market

High cost of auto-injectors, and stringent regulatory scenario are the major factors hindering growth of the global auto-injectors market. The cost of EpiPen (2-pack) increased from US$ 100 in 2007 to US$ 608. Moreover, the cost of a generic EpiPen launched in December 2016 was 300% more than that in 2007.

Key features of the study:

  • This report provides in-depth analysis of the global auto-injectors market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global auto-injectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Auto-Injectors Market, By Product Type:
    • Prefilled Auto-Injectors
    • Fillable Auto-Injectors
  • Global Auto-Injectors Market, By Disease Indication:
    • Anaphylaxis
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Others
  • Global Auto-Injectors Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Auto-Injectors Market, By Geography:
    • North America
      • By Product Type
        • Prefilled Auto-Injectors
        • Fillable Auto-Injectors
      • Disease Indication
        • Anaphylaxis
        • Multiple Sclerosis
        • Rheumatoid Arthritis
        • Others
      • By End User
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type
        • Prefilled Auto-Injectors
        • Fillable Auto-Injectors
      • Disease Indication
        • Anaphylaxis
        • Multiple Sclerosis
        • Rheumatoid Arthritis
        • Others
      • By End User
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Prefilled Auto-Injectors
        • Fillable Auto-Injectors
      • Disease Indication
        • Anaphylaxis
        • Multiple Sclerosis
        • Rheumatoid Arthritis
        • Others
      • By End User
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Prefilled Auto-Injectors
        • Fillable Auto-Injectors
      • Disease Indication
        • Anaphylaxis
        • Multiple Sclerosis
        • Rheumatoid Arthritis
        • Others
      • By End User
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Product Type
        • Prefilled Auto-Injectors
        • Fillable Auto-Injectors
      • Disease Indication
        • Anaphylaxis
        • Multiple Sclerosis
        • Rheumatoid Arthritis
        • Others
      • By End User
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Prefilled Auto-Injectors
        • Fillable Auto-Injectors
      • Disease Indication
        • Anaphylaxis
        • Multiple Sclerosis
        • Rheumatoid Arthritis
        • Others
      • By End User
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Becton, Dickinson and Company *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Sanofi S.A.
    • Pfizer, Inc.
    • Mylan N.V.
    • Novartis International AG
    • Bayer AG
    • Janssen Global Services Llc
    • Antares Pharma, Inc.
    • Amgen Inc.
    • Eli Lilly and Co.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Auto-Injectors Market, By Product Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Prefilled Auto-Injectors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Fillable Auto-Injectors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Auto-Injectors Market, By Disease Indication, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Anaphylaxis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Multiple Sclerosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Rheumatoid Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Global Auto-Injectors Market, By End User, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  7. Global Auto-Injectors Market, By Regions, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mylan N.V.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Novartis International AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bayer AG.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Janssen Global Services Llc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Antares Pharma, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Eli Lilly and Co.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Amgen, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 25 figures on “Auto-Injectors Market – Global forecast to 2027.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner